Completed
A Phase 2b Study of UGN-102 for Low Grade Intermediate Risk Non-Muscle-Invasive Bladder Cancer
NCT03558503
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
- Locations
-
- Mayo Clinic Cancer Center Phoenix, Arizona, United States
- Arkansas Urology Little Rock, Arkansas, United States
- Loma Linda University Loma Linda, California, United States
- Providence Medical Institute Santa Monica, California, United States